Discovery Medicine · Published 2026-06-18 · DOI 10.24976/discov.med.202638209.132
Jinfeng Rong, Yan Xu, Hongjia Zhu, Xue Zhou, Yan Chen, Linquan Mu
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Rong, J., Xu, Y., Zhu, H., et al. (2026). PARP Inhibitor-Sensitized Radionuclide Therapy Combined With Immune Checkpoint Inhibitors: A Review of Mechanistic Synergy, Tumor Microenvironment Remodeling, and Systemic Immune Effects. Discovery Medicine. https://doi.org/10.24976/discov.med.202638209.132